The Antibacterial Drug Candidate SBC3 is a Potent Inhibitor of Bacterial Thioredoxin Reductase

Jennie O'Loughlin; Silvia Napolitano; Fahad Alkhathami; Cillian O'Beirne; Daniel Marhöfer; Megan O'Shaughnessy; Orla Howe; Matthias Tacke; Marina Rubini

doi:10.1002/cbic.202000707

The Antibacterial Drug Candidate SBC3 is a Potent Inhibitor of Bacterial Thioredoxin Reductase

Jennie O'Loughlin
, Silvia Napolitano
, Fahad Alkhathami
, Cillian O'Beirne
, Daniel Marhöfer
, Megan O'Shaughnessy
, Orla Howe
, Matthias Tacke
, Marina Rubini

Research output: Contribution to journal › Article › peer-review

Abstract

Antibiotic resistance is a growing problem for public health and associated with increasing economic costs and mortality rates. Silver and silver-related compounds have been used for centuries due to their antimicrobial properties. In this work, we show that 1,3-dibenzyl-4,5-diphenyl-imidazol-2-ylidene silver(I) acetate/NHC*-Ag-OAc (SBC3) is a reversible, high affinity inhibitor of E. coli thioredoxin reductase (TrxR; K_i=10.8±1.2 nM). Minimal inhibition concentration (MIC) tests with different E. coli and P. aeruginosa strains demonstrated that SBC3 can efficiently inhibit bacterial cell growth, especially in combination with established antibiotics like gentamicin. Our results show that SBC3 is a promising antibiotic drug candidate targeting bacterial TrxR.

Original language	English
Pages (from-to)	1093-1098
Number of pages	6
Journal	ChemBioChem
Volume	22
Issue number	6
DOIs	https://doi.org/10.1002/cbic.202000707
Publication status	Published - 16 Mar 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

antibiotic resistance
antibiotics
inhibitors
NHC-metal complexes
thioredoxin reductase

Access to Document

10.1002/cbic.202000707

Cite this

@article{cbef5cb52e69454ca28b872d100c4415,

title = "The Antibacterial Drug Candidate SBC3 is a Potent Inhibitor of Bacterial Thioredoxin Reductase",

abstract = "Antibiotic resistance is a growing problem for public health and associated with increasing economic costs and mortality rates. Silver and silver-related compounds have been used for centuries due to their antimicrobial properties. In this work, we show that 1,3-dibenzyl-4,5-diphenyl-imidazol-2-ylidene silver(I) acetate/NHC*-Ag-OAc (SBC3) is a reversible, high affinity inhibitor of E. coli thioredoxin reductase (TrxR; Ki=10.8±1.2 nM). Minimal inhibition concentration (MIC) tests with different E. coli and P. aeruginosa strains demonstrated that SBC3 can efficiently inhibit bacterial cell growth, especially in combination with established antibiotics like gentamicin. Our results show that SBC3 is a promising antibiotic drug candidate targeting bacterial TrxR.",

keywords = "antibiotic resistance, antibiotics, inhibitors, NHC-metal complexes, thioredoxin reductase",

author = "Jennie O'Loughlin and Silvia Napolitano and Fahad Alkhathami and Cillian O'Beirne and Daniel Marh{\"o}fer and Megan O'Shaughnessy and Orla Howe and Matthias Tacke and Marina Rubini",

note = "Publisher Copyright: {\textcopyright} 2020 Wiley-VCH GmbH",

year = "2021",

month = mar,

day = "16",

doi = "10.1002/cbic.202000707",

language = "English",

volume = "22",

pages = "1093--1098",

journal = "ChemBioChem",

issn = "1439-4227",

publisher = "John Wiley and Sons Inc.",

number = "6",

}

TY - JOUR

T1 - The Antibacterial Drug Candidate SBC3 is a Potent Inhibitor of Bacterial Thioredoxin Reductase

AU - O'Loughlin, Jennie

AU - Napolitano, Silvia

AU - Alkhathami, Fahad

AU - O'Beirne, Cillian

AU - Marhöfer, Daniel

AU - O'Shaughnessy, Megan

AU - Howe, Orla

AU - Tacke, Matthias

AU - Rubini, Marina

PY - 2021/3/16

Y1 - 2021/3/16

N2 - Antibiotic resistance is a growing problem for public health and associated with increasing economic costs and mortality rates. Silver and silver-related compounds have been used for centuries due to their antimicrobial properties. In this work, we show that 1,3-dibenzyl-4,5-diphenyl-imidazol-2-ylidene silver(I) acetate/NHC*-Ag-OAc (SBC3) is a reversible, high affinity inhibitor of E. coli thioredoxin reductase (TrxR; Ki=10.8±1.2 nM). Minimal inhibition concentration (MIC) tests with different E. coli and P. aeruginosa strains demonstrated that SBC3 can efficiently inhibit bacterial cell growth, especially in combination with established antibiotics like gentamicin. Our results show that SBC3 is a promising antibiotic drug candidate targeting bacterial TrxR.

AB - Antibiotic resistance is a growing problem for public health and associated with increasing economic costs and mortality rates. Silver and silver-related compounds have been used for centuries due to their antimicrobial properties. In this work, we show that 1,3-dibenzyl-4,5-diphenyl-imidazol-2-ylidene silver(I) acetate/NHC*-Ag-OAc (SBC3) is a reversible, high affinity inhibitor of E. coli thioredoxin reductase (TrxR; Ki=10.8±1.2 nM). Minimal inhibition concentration (MIC) tests with different E. coli and P. aeruginosa strains demonstrated that SBC3 can efficiently inhibit bacterial cell growth, especially in combination with established antibiotics like gentamicin. Our results show that SBC3 is a promising antibiotic drug candidate targeting bacterial TrxR.

KW - antibiotic resistance

KW - antibiotics

KW - inhibitors

KW - NHC-metal complexes

KW - thioredoxin reductase

UR - https://www.scopus.com/pages/publications/85097593456

U2 - 10.1002/cbic.202000707

DO - 10.1002/cbic.202000707

M3 - Article

C2 - 33170522

AN - SCOPUS:85097593456

SN - 1439-4227

VL - 22

SP - 1093

EP - 1098

JO - ChemBioChem

JF - ChemBioChem

IS - 6

ER -

The Antibacterial Drug Candidate SBC3 is a Potent Inhibitor of Bacterial Thioredoxin Reductase

Abstract

UN SDGs

Keywords

Access to Document

Fingerprint

Cite this